<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">Pseudoachondroplasia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e>) and <z:hpo ids='HP_0002654'>multiple epiphyseal dysplasia</z:hpo> (MED) are <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0029422" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">osteochondrodysplasias</z:e> that result in mild to <z:hpo ids='HP_0008890'>severe short-limb dwarfism</z:hpo> and early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0003560'>osteoarthrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> and some forms of MED result from mutations in the gene for cartilage oligomeric matrix protein (COMP; OMIM 600310 [http://www3.ncbi.nlm. nih.gov:80/htbin-post/Omim/dispmim?600310]) </plain></SENT>
<SENT sid="2" pm="."><plain>We report the identification of COMP mutations in an additional 14 families with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> or MED phenotypes </plain></SENT>
<SENT sid="3" pm="."><plain>Mutations predicted to result in single-amino acid deletions or substitutions, <z:hpo ids='HP_0000001'>all</z:hpo> in the region of the COMP gene encoding the calmodulin-like repeat elements, were identified in patients with moderate to severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We also identified within this domain a missense mutation that produced MED Fairbank </plain></SENT>
<SENT sid="5" pm="."><plain>In two families, one with mild <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> and the second with a form of MED, we identified different substitutions for a residue in the carboxyl-terminal globular region of COMP </plain></SENT>
<SENT sid="6" pm="."><plain>Both the clinical presentations of these two families and the identification of COMP-gene mutations provide evidence of phenotypic overlap between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> and MED </plain></SENT>
<SENT sid="7" pm="."><plain>These data also reveal a role for the carboxyl-terminal domain in the structure and/or function of COMP </plain></SENT>
</text></document>